chronic lymphocytic leukemia

ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia
Fierce Pharma
Sun, 12/8/24 - 09:53 pm
ASH 2024
AstraZeneca
Calquence
chronic lymphocytic leukemia
CLL
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
BioSpace
Mon, 04/18/22 - 10:58 am
TG Therapeutics
ublituximab-umbralisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
Janssen gets EC approval for two new indications of Imbruvica
Pharmaceutical Business Review
Wed, 08/14/19 - 10:17 am
JNJ
Janssen
Europe
Imbruvica
Waldenström’s macroglobulinemia
chronic lymphocytic leukemia
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
Tue, 05/7/19 - 10:15 am
AstraZeneca
Calquence
clinical trials
chronic lymphocytic leukemia
AbbVie
JNJ
Imbruvica
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Thu, 03/7/19 - 09:53 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Thu, 03/7/19 - 09:35 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
TG stock sinks after setback to blood cancer trial
Fierce Biotech
Tue, 09/25/18 - 09:59 am
TG Therapeutics
FDA
ublituximab-umbralisib
CLL
chronic lymphocytic leukemia
AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Endpoints
Mon, 06/11/18 - 09:17 am
AbbVie
Roche
Venclexta
Rituxan
CLL
chronic lymphocytic leukemia
ASCO 2018 Sends TG Therapeutics Stock Soaring 10% Today
Motley Fool
Mon, 06/4/18 - 09:55 pm
TG Therapeutics
umbralisib
chronic lymphocytic leukemia
ASCO 2018
ASCO18: AbbVie blood cancer combo off to a strong start in Phase 2
Biopharma Dive
Mon, 06/4/18 - 09:37 am
AbbVie
Imbruvica
Venclexta
chronic lymphocytic leukemia
small lymphocytic lymphoma
ASCO 2018
Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.
Fierce Pharma
Mon, 01/22/18 - 05:41 pm
Novartis
Arzerra
Genmab
CLL
chronic lymphocytic leukemia
#ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
Endpoints
Sun, 12/10/17 - 11:22 pm
ASH17
AbbVie
Verastem
FDA
duvelisib
chronic lymphocytic leukemia
#ASH17: Late breaker from AbbVie, Roche highlights a blockbuster breakout opportunity for Venclexta in CLL
Endpoints
Fri, 11/24/17 - 09:25 am
ASH
AbbVie
Roche
Venclexta
CLL
chronic lymphocytic leukemia
Verastem moves closer to US filing for blood cancer drug
BioPharma Dive
Wed, 11/1/17 - 06:58 pm
Verastem
duvelisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tue, 09/19/17 - 10:23 pm
AbbVie
Roche
clinical trials
Venclexta
Rituxan
chronic lymphocytic leukemia
Roche's Leukemia Drug Approved for Next Step in Europe
Yahoo/GuruFocus
Mon, 12/12/16 - 09:30 am
Roche
chronic lymphocytic leukemia
Europe
venetoclax
Venclyxto
JNJ's Expensive Leukemia Drug Wins British Nod
Investopedia
Sun, 11/27/16 - 03:54 pm
JNJ
UK
Imbruvica
chronic lymphocytic leukemia
CLL
Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee
Yahoo/GuruFocus
Sat, 10/15/16 - 12:23 pm
Roche
AbbVie
Venclyxto
CHMP
chronic lymphocytic leukemia
CLL
venetoclax

Pages